Loading clinical trials...
Loading clinical trials...
A Multi-Center Study to Evaluate Subject Reported Outcomes With Use of Trifarotene 50 μg/g Cream in the Treatment of Moderate Facial and Truncal Acne Vulgaris
Conditions
Interventions
Trifarotene
Locations
9
United States
Galderma Investigational Site
Fort Smith, Arkansas, United States
Galderma Investigational Site
Beverly, Massachusetts, United States
Galderma Investigational Site
Portsmouth, New Hampshire, United States
Galderma Investigational Site
Philadelphia, Pennsylvania, United States
Galderma Investigational Site
Austin, Texas, United States
Galderma Investigational Site
Beaumont, Texas, United States
Start Date
March 27, 2019
Primary Completion Date
December 23, 2019
Completion Date
December 23, 2019
Last Updated
December 15, 2021
NCT07205107
NCT05891795
NCT06501560
NCT03883269
NCT07469228
NCT06415305
Lead Sponsor
Galderma R&D
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions